Overview

Insomnia remains the most prevalent sleep disorder frequently encountered in the primary care setting. Dissatisfaction with sleep, due to difficulty in falling asleep or staying asleep or waking early, remains a challenge for primary care clinicians to recognize, evaluate and manage. As primary care providers continue to exhibit an incomplete understanding of diagnosis and appropriate treatment of insomnia, this program will focus on providing clinical resources intended to improve recognition and assessment of sleep disorders while establishing collaborative treatment plans, which result in improved patient health outcomes. 

Learning Objectives

  • Review the prevalence of chronic insomnia in primary care settings, including the associations with chronic disease
  • Describe the types of chronic insomnia and challenges to better managing
  • Review pathophysiology of sleep and emerging approaches to better manage insomnia
  • Discuss the value of utilizing non-pharmacologic approaches to help manage insomnia
  • Review pharmacologic approaches to manage various insomnia presentations and how to appropriately select agents to best the needs of the patient while reducing risks 


Faculty

Alon Y. Avidan, MD, MPH, FAAN, FAASM

Profesor and Vice Chair
UCLA Department of Neurology
Director, UCLA Sleep Disorders Center
David Deffen School of Medicine at UCLA
Los Angeles, CA 

 

Suzanne Bertisch, MD, MPH

Assistant Professor of Medicine
Harvard Medical School
Division of Pulmonary, Critical Care and Sleep Medicine
Beth Israel Deaconess Medical Center
Boston, MA

David J. Seiden, MD, FAASM

Medical Director
Baptist Sleep Centers of South Florida and QPS-MRA
Sleep Medicine Specialist
First Choice Neurology
Hollywood, FL

CME Information

CME

AMA PRA Category 1 Credits

Accreditation Statement

pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Designation Statement

pmiCME designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME

AANP

Accreditation Statement

pmiCME is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider number 040308. This activity was planned in accordance with AANP Accreditation Standards and Policies.


Designation Statement

This program has been approved for 1.50 contact hours of continuing education. AANP Pharmacology credit is pending.

Commercial Supporter

Merck & Co., Inc.

Education Partner

pmiCME


Fine Print

Internet Explorer (version 9.0 and above) is the minimum supported browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

Internet Explorer (version 9.0 and above) is the minimum supported browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

pmiCME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of pmiCME to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

pmiCME Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. pmiCME, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. pmiCME is the accredited provider for this activity.

Disclosures and Conflict of Interest
pmiCME requires all individuals in a position to influence educational content for pmiCME-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. pmiCME assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by pmiCME or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.